11/04/2026
November is Lung Cancer Awareness Month, a time to recognize people living with lung cancer, along with the families, caregivers, and healthcare professionals who support them.
Despite advances in research and treatment, significant unmet needs remain for people affected by lung cancer. At Inhibrx, we remain committed to advancing oncology research, including the ongoing investigation of INBRX-106 in non-small cell lung cancer (NSCLC), as part of our broader efforts to explore potential new therapeutic approaches for patients.
Learn more about the INBRX-106 program: https://tinyurl.com/55whrp5m